🔗 Permalink

Inventor profile of:

Julia LEIBOLD

City:

Langkampfen

Country:

Austria

Published Applications:

Last publication date:

2021-09-16

Top Assignees for applications by Julia LEIBOLD

The entities that hold a legal rights for patent applications filed by inventor LEIBOLD Julia:

IMMATICS BIOTECHNOLOGIES GMBH 19 Tuebingen, Germany
Immatics Biotechologies GmbH 1 Tuebingen, Germany

Recent patent applications by LEIBOLD Julia

Julia LEIBOLD from Langkampfen, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-09-16

US20210283230A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#2 | 2021-09-09

US20210275655A1

Human necessities

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS

#3 | 2021-09-09

US20210275654A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#4 | 2021-09-09

US20210275653A1

Human necessities

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS

#5 | 2021-05-20

US20210145952A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

#6 | 2021-04-01

US20210093702A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

#7 | 2020-12-24

US20200397880A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

#8 | 2020-12-24

US20200397878A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#9 | 2020-12-10

US20200384093A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

#10 | 2020-10-15

US20200323969A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#11 | 2020-04-02

US20200102360A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

#12 | 2020-01-02

US20200000900A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#13 | 2019-12-12

US20190375809A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

#14 | 2019-12-12

US20190374626A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#15 | 2019-11-07

US20190338006A1

Chemistry; metallurgy

Peptides and combinations of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

#16 | 2019-11-07

US20190338005A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

#17 | 2019-09-12

US20190275131A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#18 | 2019-09-05

US20190270784A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers

#19 | 2019-08-08

US20190240305A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#20 | 2019-03-28

US20190091311A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#21 | 2019-02-21

US20190054160A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#22 | 2018-12-06

US20180344827A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

InventorID:

2362256 ⎘